| Unique ID issued by UMIN | UMIN000059392 |
|---|---|
| Receipt number | R000067235 |
| Scientific Title | Supporting Treatment Adherence and Resilience in Kids |
| Date of disclosure of the study information | 2025/10/14 |
| Last modified on | 2025/10/14 15:47:11 |
Supporting Treatment Adherence and Resilience in Kids
STAR KIDS
Supporting Treatment Adherence and Resilience in Kids
STAR KIDS
| Asia(except Japan) |
Asthma, Eczema, Cardiac conditions
| Cardiology | Pneumology | Pediatrics |
| Dermatology |
Others
NO
The goal of the STAR KIDS (Supporting Treatment Adherence and Resilience in Kids) research is to promote better adherence to treatment plan and advice among paediatric patients (particularly children with asthma, eczema, and cardiac condition) and their families. The needs assessment aims to provide initial insight on experiences, barriers, facilitators, and suggested improvements or new initiatives related to treatment adherence by means of interviewing children, parents, as well as Healthcare Professionals (HCPs). The results of the needs assessment will be used to create interventions/education materials/support programmes/tools with the goal to improve the quality of life and health-related outcomes of children.
Others
Improvements in patient adherence to treatment plan (inhaler use, topical therapy, oral medication), and their associated advice (exercise, dust/allergen control, environmental control, diet modification, etc.)
Exploratory
Phase III
As this is a supporting treatment adherence study, the primary outcomes are how well the participants follow the treatment plan and associated advice as directed by their doctors (and other healthcare professionals). For appropriate asthma inhaler use, this would be achieved via Medication Possession Ratio, Proportion of Days Covered, Medication Implementation/Adherence Questionnaires, medical record review, etc. For other advice this would be achieved depending on the nature of the advice, for example removal of pets by asking family members/home visit/proxy interviews, shortening of bath time by digital timer, laundry care and allergen control by home visit and purchase proof, food photograph and random checks, etc.
Heath-related Quality of Life, Step-up therapy (e.g. via GINA steps review from medical records), Hospitalization and emergency department visit, Qualitative interviews on treatment adherence, Patients' and Providers' evaluation of the intervention/support/tools/education materials, Surveillance, cost analysis, and HTA.
Interventional
Single arm
Non-randomized
Open -no one is blinded
Historical
1
Educational,Counseling,Training
| Behavior,custom |
The intervention is additional resources/supports/tools to facilitate adherence to treatment plan based on the results of a formal needs assessment. This may include home visit, directly observed therapy to improve inhaler technique, teleconsultations, help-line via chat, educational material, medication delivery, dietitian support, subsidy/cost adjustments, etc.
| 2 | years-old | <= |
| 20 | years-old | >= |
Male and Female
1. Must have an established diagnosis of asthma, atopic dermatitis or eczema, or a cardiac condition requiring long-term Warfarin therapy (e.g., atrial fibrillation, cardiac valve-related condition/replacement, post-Fontan operation).
2. Must be receiving the treatment of interest (inhaled corticosteroids for asthma, any topical treatment for atopic dermatitis or eczema, or Warfarin therapy for a cardiac condition), in KKH.
3. Must be aged 10 to 20 years
4. Singapore Citizen or Singapore Permanent Resident
5. Able to communicate in English
6. The participant must provide consent to be interviewed at least three times: the first interview will be conducted face-to-face, and the subsequent interviews will be at three months and six months, which may be face-to-face or via phone calls, depending on the participant's preference.
7. The participant must provide consent for the interviews to be audio-recorded.
1. The participant has a plan to move overseas within the next six months.
2. The participant has an unfavorable prognosis with a life expectancy of less than 24 months.
3. The participant is involved in other research or clinical trials that could interfere with the study's data collection or analysis.
4. The participant has significant cognitive or communication impairments that would hinder effective participation in interviews or the informed consent process.
100
| 1st name | Jean Yin |
| Middle name | |
| Last name | Oh |
KK Women's and Children's Hospital, SingHealth Duke-NUS, Singapore
Department of Paediatrics
229899
100 Bukit Timah Road
+6562255554
starkids+research@kkh.com.sg
| 1st name | KKH |
| Middle name | |
| Last name | General Enquiry |
KK Women's and Children's Hospital, SingHealth Duke-NUS, Singapore
Department of Paediatrics
229899
100 Bukit Timah Road
+6562255554
https://www.kkh.com.sg/
research@kkh.com.sg.
KK Women's and Children's Hospital, SingHealth Duke-NUS, Singapore
Low Tuck Kwong Foundation
Non profit foundation
Singapore
SingHealth Centralised Institutional Review Board
10 Hospital Boulevard, #19-01 SingHealth Tower, Singapore 168582
+6581263660
irb@singhealth.com.sg
NO
KK Women's and Children's Hospital (Singapore), SingHealth Duke-NUS Academic Medical Centre (Singapore)
| 2025 | Year | 10 | Month | 14 | Day |
Unpublished
Enrolling by invitation
| 2025 | Year | 08 | Month | 08 | Day |
| 2025 | Year | 08 | Month | 08 | Day |
| 2025 | Year | 08 | Month | 24 | Day |
| 2028 | Year | 08 | Month | 24 | Day |
| 2025 | Year | 10 | Month | 14 | Day |
| 2025 | Year | 10 | Month | 14 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067235